Monday, September 14, 2026

Hurom Builds Momentum in Global B2B Market With Commercial Juicer Showcase at Chicago Industry Event

Hurom showcases commercial juicers at the National Restaurant Association Show, aiming for global B2B market growth and health-conscious trends.

Human Rights Chairperson Welcomes Consensus Adoption Of UN Resolution Highlighting Misery Of North Koreans

Ahn Chang-ho welcomed the UN's resolution on North Korean human rights, urging action against severe violations and international cooperation.

How Trump’s North Korea Dialogue Could Reshape Northeast Asia: Insights from South Korea’s Unification Minister

South Korea's Unification Minister Chung Dong-young states that Trump's efforts have initiated a tectonic shift on the Korean Peninsula.

Tag: clinical trials

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm’s Epilepsy Drug Trial Partially Halted in U.S., New Enrollment Suspended

SK Biopharm's U.S. trials of epilepsy drug candidate opicopalim have been partially placed on hold by the FDA, temporarily stopping new enrollment while existing patients continue treatment.

GCCL Expands Global Partnerships at ABP 2026: Insights into Asia-Pacific Biotech Growth

GCCL, a global clinical trial specimen analysis firm, expanded its collaboration at the Asia Bio Partnering Forum 2026 in Singapore.

Hanmi Pharmaceutical to Present Phase 2 Clinical Results for Congenital Hyperinsulinism Treatment at European Conference

Hanmi Pharmaceutical will present Phase 2 data on its investigational treatment efpeglenatide (HM15136) for congenital hyperinsulinism at the 64th European Society for Paediatric Endocrinology meeting in France.

Revolutionizing Knee Treatment: How MIUChon iPSC Therapy Could Replace Joint Surgery by 2026

iPSC-based company YiPSCELL accelerates clinical trials for cartilage cell treatment MIUChon, aiming for new options before joint surgery.

GC Biopharma Leads Innovation in Cancer Treatment with AI-Powered mRNA Platform

Moderna's recent success in personalized cancer vaccine trials highlights the growing interest in mRNA technology.

CS5001: 100% Complete Response Rate in DLBCL Clinical Trial – A Game Changer for Cancer Treatment?

LigaChem Biosciences reveals clinical data for cancer drug CS5001 targeting DLBCL, developed in partnership with CStone Pharmaceuticals.

CS5001 Breakthrough: 100% Complete Remission in DLBCL Trials – What This Means for Cancer Treatment

ABL Bio's ADC candidate shows complete response in all patients in early trials for first-line treatment of DLBCL.

HLB Group’s New Cancer Drug Lirapegrafinib: What to Expect from FDA Approval on September 25?

HLB Group's drug development business is set to achieve key clinical and approval milestones in the second half of this year.

How AI is Revolutionizing Custom Cancer Vaccines: Insights from Neogen Logic’s 2027 IND Plans

Moderna and Merck's personalized cancer vaccine shows positive Phase 3 results, boosting interest in AI-based vaccine development in Korea.

PenetriumBioScience Files U.S. FDA IND for Phase 2a Trial in Advanced Solid Tumors

Penitrium Bioscience enters Phase 2a clinical trials in the U.S. for its cancer drug candidate 'Penitrium.'

SkyLabs’ CART BP Pro: The Revolutionary Ring-Style Blood Pressure Monitor Set to Gain FDA Approval in 2027

Skylabs accelerates its U.S. market entry by starting clinical trials for its ring-shaped blood pressure monitor, seeking FDA approval.

Penetrium Bio to unveil U.S. Phase 2 strategy at global symposium

Penetrium Bio will unveil its Phase 2 clinical development strategy for the next-gen cancer drug Penetrium at a global symposium next month.

IKS04: The New ADC Candidate for GI Cancer Approved by FDA – What You Need to Know

LigaChemBio's ADC platform technology enters U.S. clinical trials for gastrointestinal cancer, showcasing its competitive edge in the field.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.